Israel Englander’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-102,000
Closed -$4.62M 6186
2025
Q4
$4.62M Buy
+102,000
New +$3.73M ﹤0.01% 3099
2025
Q1
Sell
-110,000
Closed -$4.9M 6250
2024
Q4
$4.9M Buy
110,000
+59,800
+119% +$2.69M ﹤0.01% 2837
2024
Q3
$2.19M Buy
50,200
+40,200
+402% +$1.51M ﹤0.01% 3630
2024
Q2
$271K Sell
10,000
-300
-3% -$8.69K ﹤0.01% 4973
2024
Q1
$301K Sell
10,300
-9,700
-49% -$294K ﹤0.01% 5141
2023
Q4
$753K Buy
+20,000
New +$736K ﹤0.01% 4372
2021
Q2
Sell
-10,000
Closed -$1.3M 6931
2021
Q1
$1.3M Buy
+10,000
New +$1.28M ﹤0.01% 3956
2018
Q2
Sell
-10,000
Closed -$434K 4066
2018
Q1
$434K Hold
10,000
﹤0.01% 3068
2017
Q4
$485K Hold
10,000
﹤0.01% 3109
2017
Q3
$511K Buy
+10,000
New +$479K ﹤0.01% 2832

Other funds holding OMCL

Israel Englander's OMCL Position: Q2 2026 in Review

Israel Englander reduced its Omnicell (OMCL) stake by 24% in Q2 2026, selling an estimated $22.3M and leaving 1,734,375 shares worth $72M. The position accounts for 0.03% of the portfolio, ranked #684.

Israel Englander first reported a position in OMCL in Q2 2013 and has held it in 37 quarters since. The position peaked at $79M in Q4 2025. 304 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • Israel Englander held 1,734,375 shares of Omnicell worth $72M as of Q2 2026.
  • Israel Englander sold 554,195 Omnicell shares in Q2 2026, an estimated $22.3M.
  • Omnicell made up 0.03% of Israel Englander's portfolio in Q2 2026, its #684 holding.
  • Israel Englander first reported a position in Omnicell in Q2 2013 and has held it in 37 quarters since.
  • Israel Englander's Omnicell position peaked at $79M in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.